Sharma East India Hospitals & Medical Research Ltd
Fundamental Score
Sharma East India Hospitals & Medical Research Ltd Share Price Live NSE/BSE
Profitability Metrics
Return on Equity
Return on Capital Employed
Operating Profit Margin (5Y)
Dividend Yield
Valuation Metrics
Price to Earnings
Market Capitalization
Industry P/E
Growth Metrics
YoY Quarterly Profit Growth
YoY Quarterly Sales Growth
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Financial Health
Debt to Equity
Interest Coverage
Free Cash Flow (5Y)
Ownership Structure
Promoter Holding
FII Holding
DII Holding
Pledged Percentage
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Market Data Analysis & Educational Insights
Educational evaluation of SHARMEH across key market metrics for learning purposes.
Positive Indicators
4 factors identified
Consistent Growth Track Record (13.06% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.
Strong Profit Growth Track Record (29.06% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.
Balanced Promoter Holding (53.63%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral, reducing forced-selling risk.
Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.
Risk Factors
4 factors identified
Below-Average Return on Equity (9.36%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.
High P/E Ratio
Observation: Stock may be overvalued relative to earnings.
Analysis: P/E above 30 requires strong growth execution to justify current valuations.
Small Market Cap
Observation: Higher investment risk due to limited size.
Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.
Financial Statements
Comprehensive financial data for Sharma East India Hospitals & Medical Research Ltd
About SHARMEH
Business Overview
Sharma East India Hospitals & Medical Research Ltd, a multi-specialty hospital, provides medical and healthcare services. The company runs hospital in the name of Jaipur Hospital. The company was incorporated in 1989 and is based in Jaipur, India.
Company Details
Key Leadership
Corporate Events
SHARMEH Stock Details & Analysis
Key Financial Metrics
Growth & Valuation
Frequently Asked Questions
What is the current price of Sharma East India Hospitals & Medical Research Ltd (SHARMEH)?
As of 29 Jan 2026, 10:36 am IST, Sharma East India Hospitals & Medical Research Ltd (SHARMEH) is currently trading at ₹99.10. The stock has a market capitalization of ₹42.05 (Cr).
Is SHARMEH share price Overvalued or Undervalued?
SHARMEH is currently trading at a P/E ratio of 32.35x, compared to the industry average of 39.28x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.
What factors affect the Sharma East India Hospitals & Medical Research Ltd share price?
Key factors influencing SHARMEH's price include its quarterly earnings growth (Sales Growth: 3.99%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Sharma East India Hospitals & Medical Research Ltd a good stock for long-term investment?
Sharma East India Hospitals & Medical Research Ltd shows a 5-year Profit Growth of 29.06% and an ROE of 9.36%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.40 before investing.
How does Sharma East India Hospitals & Medical Research Ltd compare with its industry peers?
Sharma East India Hospitals & Medical Research Ltd competes with major peers in the Healthcare Service Provider. Investors should compare SHARMEH's P/E of 32.35x and ROE of 9.36% against the industry averages to determine its competitive standing.
What is the P/E ratio of SHARMEH and what does it mean?
SHARMEH has a P/E ratio of 32.35x compared to the industry average of 39.28x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹32 for every ₹1 of annual earnings.
How is SHARMEH performing according to Bull Run's analysis?
SHARMEH has a Bull Run fundamental score of 40.8/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.
What sector and industry does SHARMEH belong to?
SHARMEH operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Sharma East India Hospitals & Medical Research Ltd.
What is Return on Equity (ROE) and why is it important for SHARMEH?
SHARMEH has an ROE of 9.36%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Sharma East India Hospitals & Medical Research Ltd generates profits from shareholders' equity.
How is SHARMEH's debt-to-equity ratio and what does it indicate?
SHARMEH has a debt-to-equity ratio of 0.40, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.
What is SHARMEH's dividend yield and is it a good dividend stock?
SHARMEH offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.
How has SHARMEH grown over the past 5 years?
SHARMEH has achieved 5-year growth rates of: Sales Growth 13.06%, Profit Growth 29.06%, and EPS Growth N/A%.
What is the promoter holding in SHARMEH and why does it matter?
Promoters hold 53.63% of SHARMEH shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.
What is SHARMEH's market capitalization category?
SHARMEH has a market capitalization of ₹42 crores, placing it in the Small-cap category.
How volatile is SHARMEH stock?
SHARMEH has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is the 52-week high and low for SHARMEH?
SHARMEH has a 52-week high of ₹N/A and low of ₹N/A.
What is SHARMEH's operating profit margin trend?
SHARMEH has a 5-year average Operating Profit Margin (OPM) of 7.07%, indicating the company's operational efficiency.
How is SHARMEH's quarterly performance?
Recent quarterly performance shows YoY Sales Growth of 3.99% and YoY Profit Growth of -5.88%.
What is the institutional holding pattern in SHARMEH?
SHARMEH has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the stock.